New myositis classification criteria—what we have learned since Bohan and Peter V Leclair, IE Lundberg Current rheumatology reports 20, 1-8, 2018 | 109 | 2018 |
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients A Meyer, Y Troyanov, J Drouin, G Oligny-Longpré, O Landon-Cardinal, ... Arthritis Research & Therapy 22, 1-10, 2020 | 66 | 2020 |
Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: a systematic review V Leclair, M Regardt, S Wojcik, M Hudson, ... PloS one 11 (8), e0160753, 2016 | 43 | 2016 |
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies O Landon-Cardinal, A Baril-Dionne, S Hoa, A Meyer, V Leclair, ... RMD open 6 (2), e001357, 2020 | 33 | 2020 |
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study V Leclair, AS Galindo-Feria, M Dastmalchi, M Holmqvist, IE Lundberg Rheumatology 58 (7), 1214-1220, 2019 | 29 | 2019 |
Polymyositis: does it really exist as a distinct clinical subset? V Leclair, A Notarnicola, J Vencovsky, IE Lundberg Current Opinion in Rheumatology 33 (6), 537-543, 2021 | 26 | 2021 |
Successful lung transplantation in a case of rapidly progressive interstitial lung disease associated with antimelanoma differentiation-associated gene 5 antibodies V Leclair, A Labirua-Iturburu, IE Lundberg The Journal of Rheumatology 45 (4), 581-583, 2018 | 25 | 2018 |
Histopathological features of systemic sclerosis-associated myopathy: a scoping review F Lefebvre, M Giannini, B Ellezam, V Leclair, Y Troyanov, S Hoa, ... Autoimmunity Reviews 20 (7), 102851, 2021 | 23 | 2021 |
Scleromyositis: a distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis M Giannini, B Ellezam, V Leclair, F Lefebvre, Y Troyanov, M Hudson, ... Frontiers in Immunology 13, 974078, 2023 | 22 | 2023 |
Autoantibody profiles delineate distinct subsets of scleromyositis V Leclair, J D’Aoust, G Gyger, O Landon-Cardinal, A Meyer, E O'Ferrall, ... Rheumatology 61 (3), 1148-1157, 2022 | 22 | 2022 |
Acute coronary syndrome in idiopathic inflammatory myopathies: a population-based study V Leclair, J Svensson, IE Lundberg, M Holmqvist The Journal of rheumatology 46 (11), 1509-1514, 2019 | 16 | 2019 |
Subsets in systemic sclerosis: one size does not fit all V Leclair, M Hudson, SM Proudman, WM Stevens, MJ Fritzler, M Wang, ... Journal of Scleroderma and Related Disorders 1 (3), 298-306, 2016 | 14 | 2016 |
Epidemiology of the idiopathic inflammatory myopathies T Khoo, JB Lilleker, BYH Thong, V Leclair, JA Lamb, H Chinoy Nature Reviews Rheumatology 19 (11), 695-712, 2023 | 13 | 2023 |
Distribution and trajectory of direct and indirect costs of idiopathic inflammatory myopathies V Leclair, J Moshtaghi-Svensson, M Regardt, M Hudson, IE Lundberg, ... Seminars in Arthritis and Rheumatism 51 (5), 983-988, 2021 | 11 | 2021 |
Recent clinical trials in idiopathic inflammatory myopathies V Leclair, IE Lundberg Current Opinion in Rheumatology 29 (6), 652-659, 2017 | 11 | 2017 |
Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis B Ellezam, V Leclair, Y Troyanov, I Bersali, M Giannini, S Hoa, ... Neuropathology and Applied Neurobiology 48 (7), e12840, 2022 | 10 | 2022 |
Capillary basement membrane reduplication in myositis patients with mild clinical features of systemic sclerosis supports the concept of ‘scleromyositis’ B Ellezam, V Leclair, Y Troyanov, A Meyer, M Hudson, ... Acta Neuropathologica 142, 395-397, 2021 | 8 | 2021 |
Pain in autoimmune inflammatory myopathies: a scoping review V Leclair, H Tsui, M Hudson RMD open 9 (1), e002591, 2023 | 7 | 2023 |
ACR/EULAR criteria for myositis and systemic sclerosis lack sensitivity for scleromyositis A Meyer, V Leclair, O Landon-Cardinal, B Ellezam, J D'Aoust, M Giannini, ... ARTHRITIS & RHEUMATOLOGY 71, 2019 | 7 | 2019 |
Canadian Inflammatory Myopathy Study (CIMS) V Leclair, M Regardt, S Wojcik, M Hudson Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy …, 2016 | 6 | 2016 |